Hearing impairment in patients with myotonic dystrophy type 2 by van Vliet, J, Tieleman, AA, van Engelen, BGM, Bassez, G, Servais, L, Béhin, A, Stojkovic, T, Meulstee, J, Engel, JAM, Lamas, G, Eymard, B, Verhagen, WIM, Mamelle, E

Relationship between muscle impairments, postural stability, and gait parameters assessed with lower-trunk accelerometry in myotonic dystrophy type 1 by Bachasson, D, Moraux, A, Ollivier, G, Decostre, V, Ledoux, I, Gidaro, T, Servais, L, Behin, A, Stojkovic, T, Hébert, LJ, Puymirat, J, Eymard, B, Bassez, G, Hogrel, J-Y

Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice by Klein, AF, Varela-Muino, MA, Arandel, L, Holland, A, Naouar, N, Arzumanov, A, Seoane, D, Revillod, L, Bassez, G, Ferry, A, Jauvin, D, Gourdon, G, Puymirat, J, Gait, MJ, Furling, D, Wood, MJA